Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
340B keeps rural hospitals alive. Big Pharma wants it gone
Fewer than half of U.S. hospitals had a profit margin of more than 5% in 2023, and 39% lost money altogether. In many cases, the outside revenue streams were the difference between staying open and shutting down. “In 2024, 507 out of the…
Sun Pharma, Grünenthal Are Said to Vie for US-Listed Organon
Sun Pharmaceutical Industries Ltd. and Germany's Grünenthal are among firms vying for New York-listed women's health-care company Organon & Co., according to people familiar with the matter. India's biggest pharmaceutical firm and closely held…
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing
Piramal Pharma Solutions is a global leader in antibody-drug conjugate (ADC) development and manufacturing, leveraging over 20 years of specialized experience to support partners from early-stage to commercialization. Ajinomoto Bio-Pharma Services…
Organon gets buyout interest from Sun Pharma, Grünenthal (OGN)
Organon (OGN) shares added ~6% in the premarket on Thursday after Bloomberg reported that India's Sun Pharmaceutical Industries Ltd. and German drugmaker Grünenthal are competing to acquire the U.S.-based women's healthcare company. According…
Traws Pharma, Inc. (TRAW) Q4 2025 Earnings Call Transcript
Traws Pharma, Inc. (TRAW) Q4 2025 Earnings Call April 15, 2026 4:30 PM EDT Iain Dukes - CEO, Secretary & Director Charles Parker - Chief Financial Officer John Fraunces - Lifesci Advisors, LLC Ladies and gentlemen, thank you for standing by.
TME Pharma Announces Publication of NOX-A12 'Triple Therapy' Phase 1/2 Expansion Arm A Findings from GLORIA trial in Nature Communications
TME Pharma Announces Publication of NOX-A12 “Triple Therapy” Phase 1/2 Expansion Arm A Findings from GLORIA trial in Nature Communications Berlin, Germany, April 16, 2026, 08.00am CET – TME Pharma N.V. (Euronext Growth Paris:…
Astellas Pharma (OTCMKTS:ALPMY) Shares Gap Down - Time to Sell?
Astellas Pharma Inc. (OTCMKTS:ALPMY - Get Free Report) shares gapped down before the market opened on Thursday. The stock had previously closed at $16.46, but opened at $15.95. Astellas Pharma shares last traded at $16.2850, with a volume of 18,263…
Pharma Mar (PHMMF) Expected to Announce Quarterly Earnings on Thursday
PharmaMar is expected to announce quarterly results on Thursday, April 23, with analysts projecting earnings of $0.2789 per share and revenue of $43.133 million. The stock opened at $106.48 and trades above its 50-day and 200-day moving averages…
Ascendis Pharma A/S (NASDAQ:ASND) Price Target Raised to $292.00
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) had its price objective boosted by equities researchers at Bank of America from $262.00 to $292.00 in a research report issued on Thursday, Benzinga reports. The firm currently has a 'buy' rating…
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Short Interest Down 25.0% in March
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO - Get Free Report) saw a large decline in short interest in the month of March. As of March 31st, there was short interest totaling 206,345 shares, a decline of 25.0% from the March 15th total of…
Charterhouse agrees Animalcare take-private as vet pharma sector sees high pet ownership but increasing scrutiny; Eurazeo targets Mittelstand with Munich office
A verification email is on its way to you. Please check your spam or junk folder just in case. If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email:.
Sumitomo Mitsui Trust Group Inc. Acquires 166,403 Shares of Royalty Pharma PLC $RPRX
Sumitomo Mitsui Trust Group Inc. raised its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 15.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,268,044…
Stock Market Today: How Will Sensex, Nifty 50 Trade On April 16?
The Indian stock market benchmark bourses Sensex and Nifty 50 are expected to witness a gap up opening, following the rally in global markets as a result of rising expectation over the second round US-Iran peace talks and de-escalation in the…
Indian Stock Markets Rally: Sensex, Nifty Up Amid US-Iran Truce Hopes & Global Optimism
Indian stock markets, including the Sensex and Nifty, surged in early trade, buoyed by renewed hopes for a US-Iran truce that has alleviated geopolitical tensions and moderated crude oil prices, coupled with positive global market sentiment and…
Stock Market Opening Bell: Sensex Surges 0.73%, Nifty 50 Rises 0.64%
Stock Market Opening Bell: The Indian benchmark stock market indices Nifty 50, and Sensex witnessed a gap up opening on Thursday, April 16, after rising hopes pinned to a possible de-escalation in the Middle East after the second round of US-Iran…
Receive a Daily briefing on Pharma Industry News
Get Started